CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized Phase 2 Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Subjects With Advanced Pancreatic Adenocarcinoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00536770
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:34:53.699353+00:00
Published At: 2007-11-06T00:00:00+00:00
Record Updated At: 2007-11-06
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Pancreatic Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2007-11-06"
protocolSection.identificationModule.nctId: "NCT00536770"
protocolSection.identificationModule.officialTitle: "A Randomized Phase 2 Study of Gemcitabine \u00b1 Erlotinib and DN-101 Versus Gemcitabine \u00b1 Erlotinib and Placebo in Subjects With Advanced Pancreatic Adenocarcinoma"
protocolSection.statusModule.overallStatus: "SUSPENDED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.